Skip to main content
. 2016 Jun 15;7(8):780–784. doi: 10.1021/acsmedchemlett.6b00169

Figure 1.

Figure 1

(a) Chemical structures of the hHint1 substrates (compounds 1 and 2) and a previously reported hHint1 inhibitor (compound 3). (b) Design of the new generation hHint1 inhibitors with an acyl-sulfamate or sulfamide backbone to improve solubility and potency over compound 3.